2023
Update on Measuring Ketones
Huang J, Yeung A, Bergenstal R, Castorino K, Cengiz E, Dhatariya K, Niu I, Sherr J, Umpierrez G, Klonoff D. Update on Measuring Ketones. Journal Of Diabetes Science And Technology 2023, 18: 714-726. PMID: 36794812, PMCID: PMC11089855, DOI: 10.1177/19322968231152236.Peer-Reviewed Original ResearchDiabetic ketoacidosisInsulin deficiencyKetone bodiesImmune checkpoint inhibitor therapyRisk of DKACheckpoint inhibitor therapyLow-carbohydrate dietLow carbohydrate availabilityInhibitor therapyInterstitial fluidSGLT2 inhibitorsUrine ketonesInsulin insufficiencyFree fatty acidsBlood ketonesCarbohydrate dietDiabetes treatmentUS FoodDrug AdministrationCare testAlcohol useKetone testEnergy substratesLipolysis increasesKetone concentrations
2018
Suppression of Ketogenesis in Type 1 Diabetes Is Not Delayed by SGLT2 Inhibitor Therapy
SIEBEL S, PATEL N, GALDERISI A, CARRIA L, TAMBORLANE W, SHERR J. Suppression of Ketogenesis in Type 1 Diabetes Is Not Delayed by SGLT2 Inhibitor Therapy. Diabetes 2018, 67 DOI: 10.2337/db18-117-lb.Peer-Reviewed Original ResearchPlasma glucoseSGLT2i useBHB levelsMedtronic MiniMedBoehringer Ingelheim GmbHSGLT2 inhibitor therapyInterruption studiesRapid-acting insulinType 1 diabetesRisk of DKABasal insulin infusionEli LillySuppression of ketogenesisCanagliflozin therapyRescue doseSGLT2i therapySGLT2i treatmentBasal insulinInhibitor therapySGLT2 inhibitorsT1D patientsAdjunctive agentsMetabolic decompensationInsulin infusionJanssen Pharmaceuticals